KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Free Cash Flow (2017 - 2025)

Elanco Animal Health's Free Cash Flow history spans 9 years, with the latest figure at $46.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 64.62% year-over-year to $46.0 million; the TTM value through Dec 2025 reached $284.0 million, down 27.92%, while the annual FY2025 figure was $284.0 million, 27.92% down from the prior year.
  • Free Cash Flow for Q4 2025 was $46.0 million at Elanco Animal Health, down from $127.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $273.0 million in Q2 2022 and bottomed at -$169.0 million in Q1 2023.
  • The 5-year median for Free Cash Flow is $118.0 million (2023), against an average of $70.7 million.
  • The largest annual shift saw Free Cash Flow crashed 576.47% in 2022 before it surged 773.68% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $124.0 million in 2021, then crashed by 151.61% to -$64.0 million in 2022, then soared by 281.25% to $116.0 million in 2023, then grew by 12.07% to $130.0 million in 2024, then crashed by 64.62% to $46.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Free Cash Flow are $46.0 million (Q4 2025), $127.0 million (Q3 2025), and $180.0 million (Q2 2025).